Should Investors Consider CRH Medical Corp?

After selling off close to 20% this past Friday, investors may want to consider shares of CRH Medical Corp (TSX:CRH).

smiling female doctor

Photo: Ilmicrofono Oggiono. Licence: CC by 2.0. Source: https://www.flickr.com/photos/115089924@N02/16070083419

Now trading under $10 for the first time since March 9th, shares of CRH Medical Corp (TSX:CRH) sold off from Thursday’s close of $12.14 to close the week at $9.90 on Friday.

Although there were no major press releases or announcements, shares still tumbled. While this is never a good sign, investors need not overreact. While the focus of the majority of articles on Motley Fool are about dividend-paying value stocks, investors still need to look at the pipeline of value stocks “to-be.”

Although it is highly likely that today’s growth stock will mature and become a value stock, it does not mean we jump at any price. With a current market capitalization close to $715 million, shareholders may only be at the beginning of a major breakout.

The company is involved in the servicing of physicians in the realm of gastrointestinal diseases, in addition to providing anesthesiology services to doctors in the United States. Operating in the growing medical field, the company is more than a feel-good story. Looking at the income statement, the company has delivered positive earnings over the 2016 fiscal year which ended on December 31st. The earnings per share (EPS) were $0.14 during the year. EPS were $0.06 in 2015, $0.03 in 2014, and $0.05 in 2013.

While earnings have been relatively minuscule, the good news is management has not focused on growth at all costs. While revenues have increased from $7.68 million in 2013 to $78.35 million in 2016, the profit and cash flows have given investors no reason to worry.

Cash flow from operations (CFO) has been positive for the past four years. While it was barely positive in 2013 and 2014, the number jumped to $17.96 million in 2015 and improved further to $32.92 Million in 2016. Clearly the company has the ability to generate positive cash flow.

While waiting for the growth story to play out, investors have very little to worry about. Currently, the company has assets totaling $163 million and liabilities of $103 million. Long term debt makes up no more than $40 million as of December 31st, 2016. To put the short term concerns to rest, current assets total $21.75 million with current liabilities reaching $12.09 million. Cash on the balance sheet totals $9.5 million.

Getting back to the bad news of the market selloff this past Friday, shares are still on a healthy bull run. Evaluating the technical indicators prior to the selloff, the share price traded above the 10-day, 50-day, and 200-day simple moving averages (SMAs) on Thursday. After the selloff however, the share price crossed below the 10-day SMA and slightly below the 50-day SMA.

It would seem the run was a little too much for a company still trying to reach a grown-up size. With a compounded annual growth rate (CAGR) in revenues of 116% from 2013 to 2016, shareholders may still have to be patient for this company to reach full potential and possibly even longer to be considered a value investment.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Goldsman has no position in any stocks mentioned. The Motley Fool owns shares of CRH Medical.

More on Investing

money cash dividends
Stocks for Beginners

Where to Invest $10,000 in April 2024

If you've already created a diversified portfolio and are looking for more options from a windfall, here is where I…

Read more »

data analyze research
Investing

The Ultimate TSX Stock to Buy With $1,000 Right Now

Brookfield Asset Management (TSX:BAM) is one of the best Canadian stocks to buy for those looking to put capital to…

Read more »

young woman celebrating a victory while working with mobile phone in the office
Dividend Stocks

3 CRA Benefits Most Canadians Can Grab in 2024

You can save on taxes by claiming the dividend tax credit on Fortis Inc (TSX:FTS) shares.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »